Course curriculum

  • 1

    General Information

    • Learning Objectives

    • Course Overview
  • 2

    SESSION 1 – Aortic Valve Disease

    • Anatomy of the aortic valve and implications for TAVI | Y. Ho

    • How imaging can guide decision making | J. J. Bax

    • The Heart Team: selecting patients, current indications & outcomes | T. Pilgrim

    • What do the guidelines say? | V. Delgado

    • Lifetime management of patients with aortic stenosis | T. Pilgrim

    • Assessing and management of mitral regurgitation in HF | A. Duncan

    • Role of CT in selection and follow up of TAVI patients | S. Mirsadraee

    • List of Publications - Session 1

    • Quiz Session 1
  • 3

    SESSION 2 – Mitral Valve Disease

    • Anatomy and imaging of the mitral valve | J. J. Bax

    • Mitral valve disease in HF | B. Iung

    • Indications for transcatheter mitral valve repair: structural vs. functional MR | G. Nickenig

    • What do the guidelines say? | A. Vahanian

    • TEE for assessment of mitral regurgitation in HF | A. Vazir

    • Live in-a-box: Mitral Valve Repair | F. Maisano

    • Case-based decision making for Mitral Valve Repair | M. Zuber

    • List of Publications - Session 2

    • Quiz Session 2
  • 4

    SESSION 3 –Right Heart Failure & Tricuspid Regurgitation (TR)

    • Cather-based procedures in TR | G. Nickenig

    • Imaging of the right heart & tricuspid regurgitation in HF | J. J. Bax

    • Causes of right heart failure | S. Rosenkranz

    • Modern management of pulmonary hypertension | R. Davies

    • Management of tricuspid regurgitation | A. Duncan

    • Double valve disease | R. Smith

    • Echo Pearls: features of TR | M. Zuber

    • List of Publications - Session 3

    • Quiz Session 3
  • 5

    SESSION 4 – Cardio-Oncology / Cardiogenic Shock

    • Cancer and heart failure | A. Lyon

    • Cardio-Oncology beyond cardiac dysfunction | T. Suter

    • Follow-up of cardio-oncology patients | T. Lopez Fernandez

    • The spectrum of cardiogenic shock – infarction and/or HF | T. F. Lüscher

    • Managing cardiogenic shock – an update | H. Thiele

    • ECMO: indications and outcomes | S. Davies

    • Current management of cardiogenic shock – case examples | M. Dalby

    • List of Publications - Session 4

    • Quiz Session 4
  • 6

    SESSION 5 – Percutaneous MCS / Revascularization in Ischemic Cardiomyopathy

    • Live in-a-box: Using short-term circulatory support as a bridge to recovery | C. Hassager

    • Setting up an ECMO programme | S. Davies

    • Percutaneous LV support: Physiology -based rational management beyond the cath lab | P. Hunziker

    • Impact of short-term circulatory support– patient cases | C. Hassager

    • Diagnosing ischemia and risk assessment | A. Pazhenkottil

    • Anatomical coronary complexity and procedural risk assessment | A. Baumbach

    • Peripartum Cardiomyopathy- an update | M. Petrie

    • List of Publications - Session 5

    • Quiz Session 5
  • 7

    Course Evaluation

    • Course Evaluation Questionnaire
Please note that accreditation and certification for Module 4 - 2nd Edition is possible until 17.10.2024